Data suggest that cabozantinib and pembrolizumab can be effective in patients with advanced gastric or gastroesophageal junction cancer whose disease is resistant or refractory to immune checkpoint ...

Health Canada has approved Merck’s KEYTRUDA (pembrolizumab), an anti-programmed ... chemotherapy as a first-line treatment for adult gastric cancer patients. The combination treatment is ...

ALPMF's expanding lineup of cancer drugs, including zolbetuximab, positions them for substantial market growth and potential appreciation.

Keytruda (pembrolizumab) is a prescription drug ... (Cytoreductive treatment lowers the number of cancer cells.) Stomach cancer: Keytruda is prescribed to adults as a first-choice treatment ...

PD-1 inhibitor Keytruda (pembrolizumab) has been cleared in ... "Patients in the EU diagnosed with HER2-positive advanced gastric cancer face an aggressive disease associated with a poor prognosis ...

Updated findings from the phase 3 ENGOT-cx11/GOG-3047/KEYNOTE-A18 study (NCT04221945) show the survival advantages of ...

This Industry Satellite Symposium was presented at the European Society for Medical Oncology (ESMO) Congress 2024, held in ...

The safety and overall survival seen in the ARC-10 trial lends further support to the firm's strategy of pairing domvanalimab and zimberelimab with chemo in STAR-121.

Dr. Brian Slomovitz: Thanks, Shannon. Dr. Shannon Westin: And listeners. Thank you all for taking the time to hear about endometrial cancer. Again, this was “Pembrolizumab or Placebo, Plus Adjuvant ...

Based on the ATTRACTION-2 trail, CheckMate-649, Nivolumab monotherapy was approved in Asian countries in patients with heavily pre-treated advanced gastric cancer. Pembrolizumab was approved in ...

and PFS compared to concurrent CRT alone for newly diagnosed patients with FIGO 2014 Stage III-IVA locally advanced cervical cancer.